Cart
Your shopping cart is empty!
It's never too late to make things right :)
Page 6 - Muscle building products
GEH-VI-1204
Active substance:Peptide
Blood pressure:Can increase blood pressure, particularly at higher doses
Chemical name:17-beta-hydroxyandrost-4-en-3-one
In stock
£99.18
Active substance
Peptide
Blood pressure
Can increase blood pressure, particularly at higher doses
Chemical name
17-beta-hydroxyandrost-4-en-3-one
PEP-BO-0296
Active substance:Peptide
Also known as:Somatomedin C
Blood pressure:Can cause slight increases in blood pressure
In stock
£74.82
Active substance
Peptide
Also known as
Somatomedin C
Blood pressure
Can cause slight increases in blood pressure
DEM-VI-1310
Active substance:Peptide
Also known as:CJC-1295 without DAC, Sermorelin
Blood pressure:Minimal or no impact on blood pressure
In stock
£28.71
Active substance
Peptide
Also known as
CJC-1295 without DAC, Sermorelin
Blood pressure
Minimal or no impact on blood pressure
BIO-VI-1074
Active substance:Peptide
Also known as:CJC-1295 without DAC, Sermorelin
Blood pressure:Minimal or no impact on blood pressure
In stock
£47.85
Active substance
Peptide
Also known as
CJC-1295 without DAC, Sermorelin
Blood pressure
Minimal or no impact on blood pressure
GEH-VI-1192
Active substance:Peptide
Also known as:CJC-1295 without DAC, Sermorelin
Blood pressure:Minimal or no impact on blood pressure
In stock
£66.99
Active substance
Peptide
Also known as
CJC-1295 without DAC, Sermorelin
Blood pressure
Minimal or no impact on blood pressure
NOU-VI-1229
Active substance:Peptide
Also known as:CJC-1295 without DAC, Sermorelin
Blood pressure:Minimal or no impact on blood pressure
In stock
£78.30
Active substance
Peptide
Also known as
CJC-1295 without DAC, Sermorelin
Blood pressure
Minimal or no impact on blood pressure
CAN-BO-0077
Active substance:Peptide
Also known as:CJC-1295 without DAC, Sermorelin
Blood pressure:Minimal or no impact on blood pressure
In stock
£45.24
Active substance
Peptide
Also known as
CJC-1295 without DAC, Sermorelin
Blood pressure
Minimal or no impact on blood pressure
PEP-BO-0297
Active substance:Peptide
Also known as:CJC-1295 without DAC, Sermorelin
Blood pressure:Minimal or no impact on blood pressure
In stock
£27.84
Active substance
Peptide
Also known as
CJC-1295 without DAC, Sermorelin
Blood pressure
Minimal or no impact on blood pressure
PEP-BO-0640
Active substance:Peptide
Also known as:CJC-1295 without DAC, Sermorelin
Blood pressure:Minimal or no impact on blood pressure
In stock
£48.72
Active substance
Peptide
Also known as
CJC-1295 without DAC, Sermorelin
Blood pressure
Minimal or no impact on blood pressure
DEM-VI-1348
Active substance:Peptide
Blood pressure:Can increase blood pressure, particularly at higher doses
Chemical name:17-beta-hydroxyandrost-4-en-3-one
In stock
£45.24
Active substance
Peptide
Blood pressure
Can increase blood pressure, particularly at higher doses
Chemical name
17-beta-hydroxyandrost-4-en-3-one
CAN-BO-0079
Active substance:Peptide
Also known as:PEGylated MGF, Peg-MGF
Blood pressure:No significant impact
In stock
£44.37
Active substance
Peptide
Also known as
PEGylated MGF, Peg-MGF
Blood pressure
No significant impact
HIL-VI-5497
Active substance:Peptide
Also known as:PEGylated MGF, Peg-MGF
Blood pressure:No significant impact
In stock
£46.98
Active substance
Peptide
Also known as
PEGylated MGF, Peg-MGF
Blood pressure
No significant impact
BIO-VI-1080
Active substance:Peptide
Also known as:PEGylated MGF, Peg-MGF
Blood pressure:No significant impact
In stock
£48.72
Active substance
Peptide
Also known as
PEGylated MGF, Peg-MGF
Blood pressure
No significant impact
GEH-VI-1203
Active substance:Peptide
Also known as:PEGylated MGF, Peg-MGF
Blood pressure:No significant impact
In stock
£99.18
Active substance
Peptide
Also known as
PEGylated MGF, Peg-MGF
Blood pressure
No significant impact
PEP-BO-0298
Active substance:Peptide
Also known as:PEGylated MGF, Peg-MGF
Blood pressure:No significant impact
In stock
£51.33
Active substance
Peptide
Also known as
PEGylated MGF, Peg-MGF
Blood pressure
No significant impact
Editorial team
Created:
08/08/2025
